- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Financial investors including Ashmore Investment, Spinnaker Capital and Clearwater Capital strike a deal with the Australian telecom on their third attempt to sell the business.
The San Diego medical device company accepts an $18 per share offer months after Engaged Capital criticized its strategy.
The agreement comes amid high hopes for the Californian target's AVP-923 treatment for Alzheimer's-related agitation.
The alphabet and numeral soup of the British wireless network landscape could get a little clearer.
The former telecom monopoly said it's also received a proposal from shareholders of a rival British cellphone network, widely assumed to be Deutsche Telekom and Orange's EE.
The transaction includes an upfront payment of $850 million to the German company, followed by up to $2 billion in milestone rewards.
The two industrial manufacturers change hands in separate deals with Flowserve, and the U.K.'s IMI.
The deal values the MBK Partners portfolio company at about $690 million.
The Russian tycoon stepped in after previously agreed bidder Capricorn Automotive failed to make a scheduled payment.
The investment values the three-year-old fashion video producer at more than $150 million.